ÌǹûÅɶÔ

21.01.2025

GLP-1 receptor agonists for the treatment of steatotic liver disease

Researchers from Centre for Liver Research have published a review article in Hepatology Communications highlighting the promising role of GLP-1 receptor agonists in the treatment of steatotic liver disease (SLD).

Read article

Newyears reflection from professor Aleksander Krag.

21.01.2025

Newyears reflection from professor Aleksander Krag.

2025 is off to a strong start – Reflections on the past year and visions for the year ahead

Read article

News

25.06.2024

FLASH researchers strongly represented at the International Liver Congress 2024

The FLASH team had a strong presence at the EASL Congress 2024, held from June 5 to June 8 in Milan, Italy. This event draws thousands of specialists who gather to share knowledge and explore the latest advancements in hepatology, all with the shared objective of enhancing patient care and community outcomes.

Read article

01.05.2024

"We've been really busy." - FLASH showcases the superorgan at the Research Day 2024

On Saturday, April 20th, ÌǹûÅÉ¶Ô held its annual Research Day event, and FLASH had a booth. It was a great success among the guests and demonstrates the importance of spreading information about the liver in new and different ways.

Read article

04.04.2024

Physicians as healers: detecting liver fibrosis early may promote lifestyle changes

It is usually challenging to motivate people to change habits related to alcohol and general health, but a new study from FLASH shows that screening and a conversation with the doctor about specific liver damages can address this extensive problem.

Read article

04.04.2024

European researchers will conduct the largest trial ever in liver disease

Liver diseases account for 300,000 deaths in Europe each year. With support from the Innovative Health Initiative, a collaboration of researchers, biotechnology companies and the pharmaceutical industry aim to improve the lives and health of people with hidden liver disease by conducting the largest study ever on early detection of liver damage.

Read article

New research paper

22.02.2024

New research paper: Infections increase the risk of liver-related complications

FLASH researchers have just published a study on the negative prognostic impact of infections in patients with early stages of alcohol-related liver disease.

Read article

12.02.2024

Validation of new disease definition for patients with liver disease: FLASH study published in Lancet Gastroenterology & Hepatology

FLASH has recently had a study published in the fine journal Lancet Gastroenterology & Hepatology which tests the new disease definition for patients with fatty liver.

Read article

06.02.2024

The Albumin study (ALB-TRIAL) is starting.

We are excited to announce that we are about to start a new research project. ALB-TRIAL is a new international study which is part of the MICROB-PREDICT EU Horizon2020 consortium. This study is a collaboration of 7 countries compassing 12 hospitals. The hospitals will participate in the study by recruiting patients from the respective countries and ensuring that the study includes a total of 240 patients with cirrhosis and ascites. The aim is to investigate whether a new biomarker can be used to predict which patients with cirrhosis and ascites, who will benefit most from regular human albumin infusions.

Read article

06.02.2024

FLASH focuses on stigmatization.

13 participants have been part of our reading and writing workshops. They have read texts from well-known Danish authors and then written their own texts based on the day's topic. The result is 13 fine texts. The purpose was to have stories told by ordinary people at risk of liver disease.

Read article